BRKH · Burtech Acquisition Corp II
Substantial doubt about the company's ability to continue as a going concern.
“The Company's liquidity condition raises substantial doubt about the Company's ability to continue as a going concern for one year from issuance of these unaudited condensed financial statements.”View the 10-Q filed Aug 14, 2026
Price & Indicators
The closing range uses available history since Jul 14, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Shell Companies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRKH
this stock
Burtech Acquisition Corp II
|
$117.49M | — | — | — | 0.0% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
CCXI
Churchill Capital Corp XI
|
$785.93M | — | — | — | 6.0% |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$647.51M | +2.7% | — | — | 0.2% |
|
EVAC
EQV Ventures Acquisition Corp. II
|
$602.01M | +2.7% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BRKH | +0.6% | +0.9% | — | +0.8% | — |
| SPY | +0.1% | -0.4% | +15.1% | +0.4% | +12.9% |
| vs SPY | +0.5% | +1.3% | — | +0.4% | — |